Company Overview

RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the events business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.

  • Name

    RELX PLC

  • CEO

    Mr. Erik Engstrom M.Sc Econ, M.Sc Eng., MBA

  • Website

    www.relx.com

  • Sector

    Professional Services

  • Year Founded

    1903

Profile

  • Market Cap

    £65.44B

  • EV

    £72.23B

  • Shares Out

    1,859.51M

  • Revenue

    £9,303M

  • Employees

    36,000

Margins

  • Gross

    65.31%

  • EBITDA

    32.29%

  • Operating

    29.66%

  • Pre-Tax

    26.37%

  • Net

    20.34%

  • FCF

    27.01%

Returns (5Yr Avg)

  • ROA

    10.58%

  • ROTA

    -1,027.1%

  • ROE

    55.22%

  • ROCE

    22.19%

  • ROIC

    11.64%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    £38.88

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    £140M

  • Net Debt

    £6,820M

  • Debt/Equity

    2.19

  • EBIT/Interest

    9.32

Growth (CAGR)

  • Rev 3Yr

    9.93%

  • Rev 5Yr

    3.78%

  • Rev 10Yr

    4.74%

  • Dil EPS 3Yr

    12.8%

  • Dil EPS 5Yr

    5.19%

  • Dil EPS 10Yr

    6.85%

  • Rev Fwd 2Yr

    5.43%

  • EBITDA Fwd 2Yr

    7.59%

  • EPS Fwd 2Yr

    8.32%

  • EPS LT Growth Est

    -2.45%

Dividends

  • Yield

  • Payout

    60.41%

  • DPS

    £0.6

  • DPS Growth 3Yr

    7.95%

  • DPS Growth 5Yr

    6.74%

  • DPS Growth 10Yr

    9.17%

  • DPS Growth Fwd 2Yr

    7.19%

LSE:REL